Demant A/S updated earnings guidance for 2023. For the year the company now expects the Organic growth of 11% to 14% (previously 6% to 10%). EBIT from DKK 4,000 to 4,400 million (previously DKK 3,800 to 4,200 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
329 DKK | +0.92% | +0.12% | +11.15% |
05-29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
05-21 | Denmark's Demant Completes Sale of Cochlear Implants Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.15% | 10.32B | |
+3.79% | 18.82B | |
+8.00% | 13.92B | |
-20.38% | 2.06B | |
+3.10% | 1.74B | |
+8.31% | 1.36B | |
+6.05% | 578M | |
-.--% | 385M | |
+69.47% | 188M | |
+11.28% | 89.83M |
- Stock Market
- Equities
- DEMANT Stock
- News Demant A/S
- Demant A/S Updates Earnings Guidance for 2023